{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:52:47Z","timestamp":1769158367726,"version":"3.49.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00904","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:16:58Z","timestamp":1556669818000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Loss-of-Function in SMAD4 Might Not Be Critical for Human Natural Killer Cell Responsiveness to TGF-\u03b2"],"prefix":"10.3389","volume":"10","author":[{"given":"Lachlan P.","family":"Healy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo R.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai","family":"Rautela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte A.","family":"Slade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas D.","family":"Huntington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid M.","family":"Winship","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Souza-Fonseca-Guimaraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nri2154","article-title":"Developmental pathways that generate natural-killer-cell diversity in mice and humans","volume":"7","author":"Huntington","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/icb.2013.96","article-title":"Cell biological steps and checkpoints in accessing NK cell cytotoxicity","volume":"92","author":"Mace","year":"2014","journal-title":"Immunol Cell Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clim.2015.10.001","article-title":"Bench to bedside: NK cells and control of metastasis","volume":"177","author":"Krasnova","year":"2017","journal-title":"Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.it.2018.12.003","article-title":"The emergence of natural killer cells as a major target in cancer immunotherapy","volume":"40","author":"Souza-Fonseca-Guimaraes","year":"2018","journal-title":"Trends Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/imcb.12045","article-title":"Molecular insight into targeting the NK cell immune response to cancer","volume":"96","author":"Rautela","year":"2018","journal-title":"Immunol Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2016.10.004","article-title":"IL-15 signaling in NK cell cancer immunotherapy","volume":"44","author":"Rautela","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-beta inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci Signal."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.4049\/jimmunol.1701461","article-title":"Canonical TGF-beta signaling pathway represses human NK cell metabolism","volume":"200","author":"Zaiatz-Bittencourt","year":"2018","journal-title":"J Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.4049\/jimmunol.1202582","article-title":"Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors","volume":"190","author":"Cerdeira","year":"2013","journal-title":"J Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ni.3800","article-title":"Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells","volume":"18","author":"Gao","year":"2017","journal-title":"Nat Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cels.2017.11.010","article-title":"Resolving the combinatorial complexity of smad protein complex formation and its link to gene expression","volume":"6","author":"Lucarelli","year":"2018","journal-title":"Cell Syst."},{"key":"B12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","article-title":"Contextual determinants of TGFbeta action in development, immunity and cancer","volume":"19","author":"David","year":"2018","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ejhg.2009.35","article-title":"Hereditary haemorrhagic telangiectasia: a clinical and scientific review","volume":"17","author":"Govani","year":"2009","journal-title":"Eur J Hum Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/ni.3809","article-title":"SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-beta signaling","volume":"18","author":"Cortez","year":"2017","journal-title":"Nat Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/nprot.2007.297","article-title":"Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data","volume":"2","author":"Hawkins","year":"2007","journal-title":"Nat Protoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1084\/jem.20160869","article-title":"Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival","volume":"214","author":"Viant","year":"2017","journal-title":"J Exp Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1182\/blood-2009-11-253286","article-title":"CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells","volume":"116","author":"Juelke","year":"2010","journal-title":"Blood."},{"key":"B18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molimm.2017.06.025","article-title":"IL-18\/IL-15\/IL-12 synergy induces elevated and prolonged IFN-gamma production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation","volume":"88","author":"Lusty","year":"2017","journal-title":"Mol Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1172\/JCI90387","article-title":"CD56bright NK cells exhibit potent antitumor responses following IL-15 priming","volume":"127","author":"Wagner","year":"2017","journal-title":"J Clin Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/eji.201747299","article-title":"T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1","volume":"48","author":"Zhang","year":"2018","journal-title":"Eur J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/(SICI)1097-0320(19991101)37:3<197::AID-CYTO6>3.0.CO;2-L","article-title":"Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity","volume":"37","author":"Aubry","year":"1999","journal-title":"Cytometry."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e22842","DOI":"10.1371\/journal.pone.0022842","article-title":"Human tumour immune evasion via TGF-beta blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity","volume":"6","author":"Wilson","year":"2011","journal-title":"PLoS ONE."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00904\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:17:00Z","timestamp":1556669820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00904\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2019.00904"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00904","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]},"article-number":"904"}}